Independent evaluation of the Access to Medicine Index (summary)

Paskelbimo data: 9 kovo 2016 | kalba: EN

Technopolis Group has conducted an evaluation of the Access to Medicine Index, for which an executive summary was published. The evaluation showed that, by providing the pharmaceutical industry with a tool for learning and discussion, the Access to Medicine Index has proven a catalyst for accelerating current access-to-medicine activities and has inspired the development of new activities.

The Access to Medicine Index is published every two years by the Access to Medicine Foundation to stimulate and guide the world’s 20 largest pharmaceutical companies to do more in providing access to medicine to people in low- and middle-income countries.

For this study, Technopolis Group developed a comprehensive Theory of Change. Through many interviews with representatives from indexed and non-indexed companies, and external stakeholders, Technopolis Group was able to identify different pathways of influence and assess their absolute and relative effectiveness.

Technopolis Group has provided the Foundation with a number of recommendations for the future of the Index. These focus on ways to consolidate the achievements of the Foundation to date and further increase the impact of the current activities. Suggestions are also provided for areas in which to expand the activity portfolio.

For more information: A detailed press release is available on the website of the Access to Medicine Index.